Related by context. All words. (Click for frequent words.) 67 comorbid depression 67 neurocognitive impairment 66 comorbid anxiety 66 GH deficiency 66 comorbid disorders 65 somatoform disorders 65 STEP BD 65 schizophrenia schizoaffective disorder 65 psychiatric comorbidities 64 psychiatric comorbidity 64 schizophreniform disorder 64 depressive symptomatology 64 Comorbid 63 venous thromboembolic disease 63 Sociodemographic 63 affective disorders 63 thrombophilia 63 meta analytic review 63 T1DM 63 syndromic 63 neuroleptic 62 psychopharmacological 62 HIV HCV coinfected 62 antidepressants fluoxetine 62 syndromal 62 antiphospholipid antibodies 62 polyarticular 62 metaanalysis 62 Comorbidity 62 haematologic 62 meta regression 62 dyslipidaemia 62 alexithymia 62 HeFH 62 neuro developmental disorders 62 Pharmacologic 62 shorter telomere length 62 arterial hypertension 62 urolithiasis 62 prospective longitudinal 62 hypochondriasis 62 Clinical Practice Guideline 62 guideline concordant 62 atypical neuroleptics 62 dysthymic disorder 62 somatization disorder 62 neuropsychological impairments 62 AA Amyloidosis 62 onset diabetes mellitus 61 Major Depressive Disorder MDD 61 Major Depressive Disorder 61 Atomoxetine 61 constipation OIC 61 bivariate analyzes 61 #q# deletion syndrome 61 neuropsychiatric symptoms 61 chlamydial infection 61 affective psychosis 61 recurrent glioblastoma multiforme 61 comorbid psychiatric 61 Pervasive Developmental Disorders 61 Interpersonal psychotherapy 61 antiepileptics 61 Helicobacter pylori eradication 61 colorectal adenoma 61 leiomyomas 61 autonomic dysfunction 61 endocrinologic 61 clinicopathological 61 atypical antipsychotic medications 61 Severe Primary IGFD 61 adenotonsillectomy 61 Comorbidities 61 psychostimulant 61 G6PD deficiency 61 congenital toxoplasmosis 61 BEXXAR Therapeutic Regimen 61 fluoxetine Prozac 61 prospectively enrolled 61 somatic symptoms 61 pharmacological approaches 61 neurogenic bladder 61 clomipramine 61 clinicopathologic 61 neurocognitive functioning 61 follicular lymphoma FL 61 utero exposure 61 juvenile idiopathic arthritis JIA 61 pharmacologic treatments 61 randomized controlled trials RCTs 61 juvenile idiopathic arthritis 61 proliferative retinopathy 61 CTEPH 61 cervicitis 61 nonsevere 60 gonococcal 60 papillary renal cell carcinoma 60 Subgroup analyzes 60 coinfected patients 60 Depressive Disorder 60 meta analytic 60 EEG abnormalities 60 endophenotypes 60 aetiology 60 gastrointestinal dysfunction 60 overactive bladder symptoms 60 heritable diseases 60 hyperactivity inattention 60 thyrotropin levels 60 mania hypomania 60 internalizing disorders 60 haloperidol Haldol 60 tumor subtype 60 nonpsychotic 60 etiologic 60 postmenopausal hormone replacement 60 psychiatric morbidity 60 Suicidal ideation 60 Subtypes 60 postexposure prophylaxis 60 biopsychosocial 60 complement inhibitor eculizumab 60 sociodemographic characteristics 60 prostate cancer CaP 60 paroxetine Paxil 60 secondary amenorrhea 60 thiopurine 60 conjugated equine estrogen 60 euthymic patients 60 primary hyperparathyroidism 60 Oppositional Defiant Disorder 60 neurosensory 60 autoimmune thyroid 60 pediatric bipolar disorder 60 voiding dysfunction 60 diabetes mellitus DM 60 anticholinergic agents 60 predisposing factor 60 AGHD 60 Intervention Effectiveness CATIE 60 bronchogenic carcinoma 60 prospective multicenter study 60 varenicline Chantix 60 endometriosis ovarian cysts 60 nocturnal enuresis 60 aripiprazole Abilify 59 prospective observational studies 59 semistructured interview 59 atherothrombotic 59 BPS IC 59 sociodemographic variables 59 Mood disorders 59 chronic thromboembolic pulmonary 59 gastric carcinoma 59 APOE genotype 59 convulsive disorders 59 univariate analyzes 59 HRQOL 59 allogeneic HSCT 59 TMS Therapy 59 Hodgkin lymphoma HL 59 pulmonary hypertension PH 59 chronic periodontitis 59 sacral neuromodulation 59 etiologic factors 59 retrospective cohort 59 diagnosing ADHD 59 pharmacological therapies 59 chronic rheumatic 59 CP CPPS 59 Heavy menstrual bleeding 59 thyroid dysfunction 59 neurocognitive deficits 59 attention-deficit/hyperactivity disorder ADHD 59 venlafaxine Effexor 59 Cognitive behavioral 59 glucocorticoid therapy 59 headache abdominal pain 59 nasal polyposis 59 nonsteroidal antiinflammatory drugs 59 antenatal depression 59 pharmacologic therapies 59 ziconotide 59 psychopharmacologic 59 mood disorders 59 antidepressants SSRIs 59 diagnosable disorder 59 Arch Surg 59 ß blockers 59 euthymic 59 risperidone Risperdal 59 histologic subtype 59 neuroleptics 59 amisulpride 59 Generalized Anxiety Disorder 59 See WARNINGS 59 herpes zoster shingles 59 Genetic susceptibility 59 β blockers 59 thromboembolic disease 59 sertraline Zoloft 59 malignant neoplasms 59 hepatic insufficiency 59 functional gastrointestinal disorders 59 Meta analyzes 59 ExTRACT TIMI 59 paroxetine sertraline 59 genomewide association study 59 hereditary predisposition 59 hypereosinophilic syndrome 59 perinatal outcomes 59 neuropsychiatric diseases 59 atherothrombotic disease 59 Teriflunomide 59 neuropathologic 59 inhaled budesonide 59 patientswith 59 pathophysiological processes 59 Leukemias 59 IgA deficiency 59 androgen excess 59 retrospective cohort study 59 interpersonal psychotherapy 59 Excessive daytime sleepiness 59 acute mania 59 DSM IV diagnosis 59 NOMID 59 invasive candidiasis 59 longitudinal cohort study 59 Major depressive disorder 59 rheumatologic 59 psychiatric outpatients 59 Lennox Gastaut Syndrome 59 longitudinal observational study 59 sociodemographic factors 59 nociceptive pain 59 rheumatoid arthritis osteoarthritis ankylosing 59 bi polar disorders 59 tic disorders 59 Adjunctive 59 Cognitive impairment 59 attention-deficit/hyperactivity disorder 59 subclinical atherosclerosis 59 benign prostatic hypertrophy BPH 59 abnormal lipid 59 dissociative disorders 59 Chronic Heart Failure 59 Growth Hormone Deficiency 59 carotid atherosclerosis 59 quetiapine Seroquel 59 antiarrhythmic drug 59 neuroleptic drugs 59 HRQL 59 candidemia 58 Selective serotonin reuptake inhibitors 58 androgen deficiency 58 psychosocial variables 58 immunocompetent 58 neuro psychiatric disorders 58 primary aldosteronism 58 coexisting illnesses 58 bullous 58 hematopoietic cancers 58 Venous thromboembolism 58 recurrent venous thromboembolism 58 cystic fibrosis chronic pancreatitis 58 cerebrovascular disorders 58 etiological 58 Pharmacotherapy 58 #q#.# deletion syndrome 58 Conduct Disorder 58 renal scarring 58 #q# deletion 58 unstable angina UA 58 prodromal phase 58 Autistic Disorder 58 Bronchiectasis 58 de novo AML 58 psychotic disorders 58 tumor histology 58 testicular tumors 58 exocrine pancreatic insufficiency EPI 58 Cardiotoxicity 58 cytogenetic abnormalities 58 symptomatic BPH 58 Exclusion criteria 58 relapsed ALL 58 PDE# inhibitors 58 smoldering myeloma 58 Symptom severity 58 SSRI citalopram 58 citalopram Celexa 58 asplenia 58 pretransplant 58 serologic testing 58 chronic prostatitis chronic 58 perinatal morbidity 58 Schizoaffective Disorder 58 tricyclic antidepressant 58 gallstone disease 58 Valdoxan 58 EQ 5D 58 Adenomas 58 AML MDS 58 decompensated liver disease 58 prospective multicentre 58 follicular adenoma 58 hyperprolactinemia 58 psychopathological disorders 58 Postoperative complications 58 acute myocardial infarction MI 58 STRIDE PD 58 eosinophilic asthma 58 #F FDG PET 58 polytherapy 58 atopic sensitization 58 mitochondrial toxicity 58 torsade de pointes 58 nondemented 58 hypogonadotropic hypogonadism 58 Intravenous immunoglobulin 58 polyp recurrence 58 poststroke depression 58 CIMZIA TM certolizumab pegol 58 carotid IMT 58 Atypical antipsychotics 58 Psychiatric Disorders 58 anticonvulsant medication 58 perinatal complications 58 intractable hiccups 58 induce orthostatic hypotension 58 IPAH 58 causal pathway 58 antiplatelet medications 58 Carbamazepine 58 Hypoactive Sexual Desire Disorder 58 chorioamnionitis 58 constipation predominant irritable bowel 58 subclinical hypothyroidism 58 metastatic lymph nodes 58 reflux disease GERD 58 PROMETA protocols 58 hyperhomocysteinemia 58 noncardiac 58 aetiological 58 thetreatment 58 comorbid substance 58 prenatal exposures 58 Socioeconomic status 58 cytomegalovirus infection 58 anorexia nervosa bulimia nervosa 58 TEAEs 58 efalizumab 58 inhaled bronchodilators 58 prodromal 58 pathophysiological mechanisms 58 fluoxetine paroxetine 58 prostate carcinogenesis 58 schizophreniform 58 hemorrhagic cystitis 58 eculizumab therapy 58 Paxil paroxetine 58 ALT flares 58 nonepileptic seizures 58 INVEGA ® 58 underwent CABG 58 underwent coronary angiography 58 NMDA antagonists 58 colorectal carcinogenesis 58 psychiatric disorders 58 FDG PET imaging 58 Prozac fluoxetine 58 multiple logistic regression 58 atherosclerotic renal artery stenosis 58 beta carotene supplementation 58 G allele 58 EXJADE 58 psoriatic arthritis PsA 58 metastatic malignant 58 congenital adrenal hyperplasia 58 Heritability 58 postoperative AF 58 prodromal symptoms 58 SRBD 58 recurrent tonsillitis 58 diabetic polyneuropathy 57 venlafaxine XR 57 dysglycemia 57 Quantitative EEG 57 susceptibility loci 57 serum estradiol 57 thyroid deficiency 57 hypovitaminosis D 57 intracranial hypertension 57 hypertension diabetes mellitus 57 subclinical disease 57 dyslexia dyspraxia 57 antimuscarinic 57 suicide ideation 57 sacral nerve stimulation 57 adenoidectomy 57 dysfunctional voiding 57 diagnostic biomarker 57 Neurocognitive 57 colonoscopy sigmoidoscopy 57 Glucocorticoids 57 postmenopausal estrogen 57 recurrent abdominal pain 57 fibroids endometriosis 57 recurrent acute pancreatitis 57 oral hypoglycemic 57 observational cohort 57 Torsades de Pointes 57 symptomatic VTE 57 Electrophysiological 57 rheumatoid arthritis inflammatory bowel 57 antiandrogen 57 Lamotrigine 57 elevated ALT 57 psychiatric inpatients 57 Chlamydia pneumoniae 57 Abilify aripiprazole 57 neuropsychiatric disorder 57 pathophysiologic 57 enterocolitis 57 Diagnostic Statistical Manual 57 serum folate concentrations 57 neurodevelopmental outcome 57 Anti psychotics 57 Alzheimer Dementia 57 chromosomal anomalies 57 Diagnostic Criteria 57 extramedullary 57 ragweed allergic 57 anagrelide 57 Mindfulness Based Cognitive Therapy 57 Not Otherwise Specified 57 bipolar illness 57 tumor subtypes 57 multisystemic 57 orofacial pain 57 hypercholesterolaemia 57 vesicoureteral reflux 57 RISPERDAL ® 57 Neovascular AMD 57 postmarketing adverse 57 hepatorenal syndrome 57 atopic 57 thromboprophylaxis 57 SSRI antidepressant 57 Heterozygous Familial Hypercholesterolemia 57 Depressive symptoms 57 unfavorable cytogenetics 57 eating disorders anorexia nervosa 57 prucalopride 57 rufinamide 57 psychiatric diagnoses 57 Randomized controlled 57 nonpsychiatric 57 olanzapine LAI 57 nonpharmacologic 57 SSRI SNRI 57 generalized tonic clonic seizures 57 gastro oesophageal reflux 57 granulomatous 57 Skin sterol 57 rheumatic disorders 57 Electroconvulsive therapy 57 statins cholesterol lowering 57 neurologic abnormalities 57 osteoporotic vertebral fractures 57 ANCA associated 57 tricyclic anti depressants 57 Lu AA# 57 comorbid 57 Kraepelin 57 symptomatic intracranial 57 multicentric 57 comorbid conditions 57 lysosomal storage disease 57 HIV lipodystrophy 57 neuro degenerative disorders 57 atherothrombosis 57 non metastatic osteosarcoma 57 vWD 57 facial clefts 57 SJIA 57 idiopathic thrombocytopenic purpura 57 Tasigna prolongs 57 cerebral microbleeds 57 Temsirolimus 57 serum lipid levels 57 chest radiographs 57 diabetes dyslipidemia 57 Systemic Lupus Erythematosus 57 Accelerated Partial Breast Irradiation 57 Phenylketonuria PKU 57 microdeletions 57 Escitalopram 57 heparin induced thrombocytopenia 57 neuropsychological functioning 57 investigational atypical antipsychotic 57 perfusion abnormalities 57 hyperlipidemic 57 puerperal psychosis 57 SSc 57 Geodon ziprasidone 57 anticonvulsant medications 57 patients undergoing percutaneous 57 vaso occlusive crisis 57 invasive aspergillosis 57 obstructive sleep apnea hypopnea 57 tiagabine 57 sonographic diagnosis 57 overactive bladder syndrome 57 kidney urologic 57 renal biopsy 57 See CLINICAL PHARMACOLOGY 57 hepatic cirrhosis 57 Abdominal ultrasound 57 nosology 57 Pemphigus 57 methotrexate therapy 57 Serdolect ® 57 prognostic variables 57 Systematic Review 57 Lipodystrophy 57 HIV seroconversion 57 neuropsychological impairment 57 chronicity 57 Treatment Outcome 57 lipid abnormalities 57 Nonalcoholic fatty liver 57 psychosocial functioning 57 clinico pathological 57 abacavir Ziagen 57 CYT# potent vascular disrupting 57 clozapine Clozaril 57 GERD migraine headaches 57 treatmentof 57 terazosin 57 subsyndromal 57 Cariprazine 57 rhinosinusitis 57 dyslipidemia hypertension diabetes 57 vulvovaginal atrophy 57 Carotid Revascularization Endarterectomy vs. 57 carotid stenosis 57 antiarrhythmic medications 57 neuropsychological assessment 57 Lymph node 57 antithrombotic agents 57 aldosterone antagonist 57 postmenopausal osteoporotic women 57 bipolar disorder schizophrenia 57 Arch Intern Med 57 TF CBT 57 Posttraumatic 57 Brief Psychiatric 57 erection hardness 57 T2DM 57 susceptibility locus 57 psychoeducational 57 neurobehavioral disorder 57 Psychiatric disorders 57 esophageal gastric 57 MAGE A3 ASCI 57 aminotransferase 57 posttransplant 57 lisdexamfetamine 57 attention-deficit/hyperactivity 57 lymphoid tumors 57 hydroxyvitamin D concentrations 57 osteoid osteoma 57 myeloproliferative diseases 57 teratogenic 57 myelofibrosis polycythemia vera 57 Nonalcoholic Fatty Liver Disease 57 Pelvic inflammatory 57 Oropharyngeal Candidiasis 57 Chronic lymphocytic leukemia 57 Subgroup analysis 57 testicular germ cell 57 RET PTC rearrangements 57 functional neuroimaging 57 variceal bleeding 57 Ritalin methylphenidate 57 nondepressed 57 sonographic appearance 57 Hurthle cell 57 relapsed MM 57 MYH9 gene 57 LC#m# vaccine 57 demyelinating 57 somatization 57 neurologic disorders 57 null responder 57 orchitis 57 lipid lowering agents 57 aldosterone antagonists 57 clinically heterogeneous 57 tonsillar hypertrophy 57 colorectal liver metastases 57 psychoeducation 57 prognostic indicators 57 hyperlipidemia hypertension 57 thyroid carcinoma 57 trastuzumab Herceptin ® 57 peritumoral brain edema 57 Impaired glucose tolerance 57 neuroactive 57 dual endothelin receptor antagonist 57 RE LY trial 57 nitrofurantoin 57 proband 57 myocardial infarctions MIs 57 preoperative diagnosis 57 antidepressant efficacy 57 enteroviral infection 57 lupus scleroderma 56 anal HPV 56 hepatic encephalopathy HE 56 induced hepatotoxicity 56 Genetic variants 56 hypophosphatasia 56 Systemic Sclerosis 56 Suicidality 56 hypokalemia hypomagnesemia 56 monozygotic twin 56 abdominal laparoscopic surgery 56 antithrombotic therapy 56 sensory gating 56 chronic idiopathic thrombocytopenic purpura 56 premorbid 56 multivariate analyzes 56 Posttraumatic stress disorder 56 orofacial clefts 56 hyperphenylalaninemia HPA due 56 systemic corticosteroid 56 newer antipsychotic medications 56 lupus anticoagulant 56 Premature Ovarian Failure 56 vesicoureteral reflux VUR 56 hypercholesterolemic patients 56 prolonged QT interval 56 thorough QT 56 systemic juvenile idiopathic 56 Hutchinson Gilford progeria 56 serotonin reuptake inhibitors 56 MGUS 56 divalproex sodium 56 bacterial prostatitis 56 journal Ophthalmology 56 Imipramine 56 HIV seropositive 56 antiretroviral naïve 56 rheumatological 56 recurrent DVT 56 lymphomas leukemias 56 epididymitis 56 acetabular fractures 56 Bipolar Mania 56 VLBW infants 56 Clinical Antipsychotic Trials 56 toxicologic 56 cerebrovascular accidents 56 guanfacine extended release 56 neuropsychological deficits 56 paroxetine Seroxat 56 psychostimulants 56 Multicenter AIDS 56 advanced neoplasia 56 varicella infection 56 peripartum 56 VLBW 56 Acute Myeloid Leukaemia AML 56 logistic regression analyzes 56 rheumatic disease 56 LHRH receptor positive 56 APOE e4 56 parkinson disease 56 Psychotic Disorders 56 rheumatic diseases 56 empirically validated 56 subependymal giant cell 56 rFVIIa 56 buprenorphine implants 56 choroidal neovascularization 56 Neuropsychological 56 Antisocial Personality Disorder 56 neurocognitive dysfunction 56 neurologic complications 56 journal Molecular Psychiatry 56 LNG IUS 56 EFFEXOR XR 56 anterior uveitis 56 Juvenile Idiopathic Arthritis 56 Thromboembolic 56 #q#.# [001] 56 PPAR gamma agonists 56 proliferative diabetic retinopathy 56 piroxicam 56 overnight polysomnography 56 SIADH 56 causal pathways 56 LAB CGRP 56 MERLIN TIMI 56 Mellaril 56 multicentre prospective 56 Multiple logistic regression 56 ALI ARDS 56 ATACAND 56 Akathisia 56 Affective Disorders 56 acamprosate calcium 56 perimenopausal women 56 neurocognition 56 gallium nitrate 56 histological subtype 56 cortical thinning 56 idiopathic scoliosis 56 BRCA mutation carriers 56 OSAHS 56 latent tuberculosis infection 56 disorder OCD 56 Cognitive Impairment 56 Hepatotoxicity 56 Infusion Reactions Severe 56 MGd 56 USPSTF recommends 56 angiographically 56 confusional 56 Sjögren syndrome 56 thyrotropin 56 inflammatory rheumatic 56 pharmacotherapies 56 Anti depressant 56 hematologic abnormalities 56 Psychosomatic Research 56 DMSA 56 psychotherapies 56 atypical femur fractures 56 ketogenic diets 56 genetic locus 56 Bacterial vaginosis 56 Vagus nerve stimulation 56 Nocturia 56 pregabalin Lyrica 56 ADHD stimulant 56 late onset Pompe 56 breast carcinoma 56 somatostatin analogs 56 seropositivity 56 serotonin reuptake inhibitors SSRIs 56 obstructive sleep 56 trials RCTs 56 tricyclic antidepressants TCAs 56 hypertension coronary 56 premenstrual syndrome PMS 56 nonbacterial prostatitis 56 potentially modifiable 56 NP CRNs 56 Colon polyps 56 Research www. elsevier.com 56 Cytogenetic 56 thalidomide Thalomid 56 suicide attempters 56 nonalcoholic steatohepatitis 56 TMPRSS2 ERG fusion 56 Symptom Checklist 56 endometrial hyperplasia 56 Intervention Effectiveness 56 progranulin mutations 56 syncopal episodes 56 anticholinergic effects 56 Rilonacept 56 maturational 56 Autistic Spectrum Disorders 56 Valvular 56 congenital adrenal hyperplasia CAH 56 flutamide 56 nabilone 56 prognostic significance 56 oral prednisolone 56 ano genital warts 56 Main Outcome Measure 56 recurrent miscarriage 56 decompensated cirrhosis 56 liver transplant recipients 56 bupropion XL 56 Histologic 56 primary dysmenorrhoea 56 Diastolic Heart Failure 56 prenatally diagnosed 56 myeloproliferative neoplasms 56 obstructive airway disease 56 NNT = 56 bronchopulmonary dysplasia BPD 56 C trachomatis 56 monogenic 56 Bulimia Nervosa 56 NeuroStar TMS Therapy 56 atypical antipsychotic medication 56 epilepsy cerebral palsy 56 clobazam 56 Effexor venlafaxine 56 Desvenlafaxine 56 selective modulator 56 pyridostigmine 56 gemifloxacin 56 underlying pathophysiology 56 postoperative delirium 56 tumorigenicity 56 nephrolithiasis 56 non cirrhotic portal 56 danazol 56 HNSCC 56 depressive symptom 56 pediatric malignancies 56 parkinsonian 56 syncopal 56 adrenal suppression 56 psychiatric disorders ATI 56 radicular pain 56 hypercalciuria 56 acute leukemias 56 asthma allergic rhinitis 56 atypical hemolytic uremic syndrome 56 Brodmann Area 56 adjuvant systemic 56 noninfectious uveitis 56 number NCT# ClinicalTrials.gov 56 colorectal neoplasms 56 abdominal ultrasounds 56 affective disorder 56 pheochromocytoma 56 multivitamin supplementation 56 Non inferiority 56 Gestational 56 thromboembolic complications 56 toenail onychomycosis 56 underdiagnosis 56 Nicotine dependence 56 intracranial stenosis 56 autism spectrum disorders ASD 56 mutated K ras 56 arterial calcification 56 recurrent UTI 56 coinfection 56 aromatase inhibitors AIs 56 pathogenetic 56 TOPAMAX ® 56 nonalcoholic steatohepatitis NASH 56 autoimmune thyroiditis 56 Non Alcoholic Steatohepatitis 56 subthreshold depression 56 chronic rhinosinusitis CRS 56 affective psychoses 56 riociguat 56 System IPSS 56 persistent pulmonary hypertension 56 osteoarthritis rheumatoid arthritis 56 Vimpat R 56 acamprosate 56 dyslipidemias 56 CHAMPION PCI 56 PLCO 56 diathesis 56 agomelatine 56 psychometric properties 56 comorbid diagnoses 56 Chronic ITP 56 relapsing multiple sclerosis 56 GnRH agonist 56 antioxidant supplementation 56 herpes zoster vaccine 56 Obsessive compulsive disorder OCD 56 IDDM 56 idiopathic pulmonary arterial hypertension 56 autism dyslexia 56 atopic disorders 56 antidiabetic medications 56 HIV seronegative 56 genital ulcer 56 neurological manifestations 56 pentoxifylline 56 thyrotoxicosis 56 congenital hypothyroidism 56 atrophic gastritis 56 Hemorrhagic Stroke 56 antibiotic streptomycin 56 transcranial Doppler ultrasound 56 Autism Spectrum Disorders ASDs 56 generalized epilepsy 56 Sexsomnia 56 acromegalic patients 56 symptomatic hyponatremia 56 Interstitial cystitis 56 ECLS 56 postdischarge 56 Psychosomatics 56 colonoscopic 56 noncancer pain 56 Iron Deficiency Anemia 56 vitamin D inadequacy 56 AGGRASTAT ® tirofiban hydrochloride 56 Benign Prostatic Hyperplasia 56 percutaneous vertebroplasty 56 pharmacotherapeutic 56 antipsychotic prescribing 56 CANCIDAS 56 Rheos System 56 psychotherapeutic treatments 56 asthma rhinitis 56 bipolar affective disorder 56 myeloproliferative disorders 56 CIN2 + 56 Neurological disorders 56 Anxiety disorders 56 PEGINTRON TM 56 epilepsy multiple sclerosis 56 MMSE scores 56 euthyroid 56 IGRAs 55 Attention-Deficit/Hyperactivity Disorder ADHD 55 VaD 55 bladder incontinence 55 Acute Stress Disorder 55 treatment emergent hyperglycemia 55 convergent validity 55 prospectively randomized 55 antiphospholipid syndrome 55 urothelial carcinoma 55 β blocker 55 HBeAg negative 55 Alzheimers Disease 55 % CI #.#-#.# [008] 55 prostaglandin analogues 55 nulliparous women 55 Estrogen Receptor 55 serum leptin 55 renoprotective 55 neuropsychiatric adverse 55 manic hypomanic 55 childhood acute lymphoblastic 55 MEVACOR 55 CARE HF 55 hereditary hemochromatosis 55 gastroesophageal reflux GERD 55 malignant polyps 55 smoldering multiple myeloma 55 Y BOCS 55 serum retinol 55 beta blocker therapy 55 malignant lymphomas 55 miglustat 55 bronchial hyperresponsiveness 55 Treating Chronic 55 Tardive Dyskinesia 55 olanzapine quetiapine 55 Quetiapine 55 Edinburgh Postnatal Depression 55 thyroid nodules 55 Carbaglu 55 #:#-# [029] 55 desvenlafaxine succinate 55 diabetic retinopathy DR 55 acid ethyl esters 55 Evaluation WISE 55 sJIA 55 exploratory endpoints 55 degenerative neurological diseases 55 cryptogenic stroke 55 HIV coinfected 55 pyelonephritis 55 Paliperidone ER 55 Nesiritide 55 multivariable analysis 55 subthreshold 55 Dental caries 55 comorbid ADHD 55 AVAPRO 55 Alcohol Dependence 55 nasopharyngitis headache 55 polymyalgia rheumatica 55 Zoloft sertraline 55 postmenopausal hormone 55 Tolvaptan 55 Pharmacological 55 inversely associated 55 fistulizing CD 55 decompensated heart failure 55 Reminyl galantamine 55 nonmalignant 55 gestational diabetes mellitus 55 levetiracetam Keppra 55 pharmacological interventions 55 methylphenidate Ritalin 55 chlamydial